Scarica l'app Stockscreener
58.13
5.44%
-3.315
Precedente Chiudi:
$61.45
Aprire:
$61.23
Volume 24 ore:
2.03M
Relative Volume:
0.54
Capitalizzazione di mercato:
$11.40B
Reddito:
$13.65B
Utile/perdita netta:
$169.86M
Rapporto P/E:
54.04
EPS:
1.0758
Flusso di cassa netto:
$412.12M
1 W Prestazione:
-7.42%
1M Prestazione:
-18.65%
6M Prestazione:
+45.06%
1 anno Prestazione:
+181.27%
Intervallo 1D:
$57.51
$62.03
Intervallo di 1 settimana:
$57.51
$64.25
Portata 52W:
$20.77
$73.75
Brightspring Health Services Inc Stock (BTSG) Company Profile
Nome
Brightspring Health Services Inc
Settore
Industria
Telefono
502-394-2100
Indirizzo
805 N. WHITTINGTON PARKWAY, LOUISVILLE
Compare BTSG vs VEEV, TEM, HQY, TXG
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BTSG
Brightspring Health Services Inc
|
58.09 | 14.13B | 13.65B | 169.86M | 412.12M | 1.0758 |
VEEV
Veeva Systems Inc
|
237.47 | 31.59B | 3.32B | 941.65M | 1.64B | 5.6161 |
TEM
Tempus Ai Inc
|
54.71 | 7.73B | 1.36B | -302.91M | -219.93M | -1.7182 |
HQY
Healthequity Inc
|
105.94 | 8.28B | 1.34B | 230.70M | 440.96M | 2.6695 |
TXG
10 X Genomics Inc
|
59.91 | 5.83B | 638.78M | -22.66M | 122.18M | -0.1744 |
Brightspring Health Services Inc Stock (BTSG) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-12 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-12-11 | Iniziato | Stephens | Overweight |
| 2025-12-08 | Iniziato | William Blair | Outperform |
| 2025-11-13 | Iniziato | BMO Capital Markets | Outperform |
| 2025-06-23 | Iniziato | TD Cowen | Buy |
| 2024-12-12 | Iniziato | CJS Securities | Market Outperform |
| 2024-10-11 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2024-06-21 | Iniziato | BTIG Research | Buy |
| 2024-03-06 | Iniziato | HSBC Securities | Buy |
| 2024-02-27 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2024-02-20 | Iniziato | BofA Securities | Buy |
| 2024-02-20 | Iniziato | Deutsche Bank | Hold |
| 2024-02-20 | Iniziato | Goldman | Buy |
| 2024-02-20 | Iniziato | Guggenheim | Buy |
| 2024-02-20 | Iniziato | Jefferies | Buy |
| 2024-02-20 | Iniziato | Leerink Partners | Outperform |
| 2024-02-20 | Iniziato | Morgan Stanley | Overweight |
| 2024-02-20 | Iniziato | UBS | Buy |
| 2024-02-20 | Iniziato | Wells Fargo | Overweight |
Mostra tutto
Brightspring Health Services Inc Borsa (BTSG) Ultime notizie
Brightspring Health Services Inc - TradingKey
BlackRock (BTSG holder) discloses 12% BrightSpring Health Services ownership in 13G/A - Stock Titan
Brightspring Health Services Inc (BTSG) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
BrightSpring Health Services, Inc. (BTSG) Stock Analysis: A Healthcare Giant with 25.6% Revenue Growth and Strong Buy Ratings - DirectorsTalk Interviews
Brightspring Health Services Inc (BTSG) Cash Flow - TradingKey
BTSG|Brightspring Health Services Inc|Price:72.910|Chg%:+3.070 - TradingKey
2 Reasons to Like BTSG (and 1 Not So Much) - Yahoo Finance
BrightSpring Health Services, Inc. (BTSG) Earnings Expected to Grow: Should You Buy? - Yahoo Finance
BTSG Q2'26 Earnings: revenue estimate is 3.66B USD - TradingView
Brightspring Health Services Inc (BTSG) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Responsive Playbooks and the BTSGU Inflection - Stock Traders Daily
Behavioral Patterns of BTSG and Institutional Flows - Stock Traders Daily
BrightSpring Health Services, Inc. Stock 12‑Month Price Target Raised to $78, Implies 12% Upside - TradingView
BrightSpring Health Services (NASDAQ:BTSG): High Growth Momentum Stock Flashing a Breakout Setup - ChartMill
ETFs Investing in BrightSpring Health Services, Inc. Units Stocks - TradingView
Top Definium Therapeutics (DFTX) Competitors 2026 - MarketBeat
BrightSpring Health Services (BTSG): Growth Potential In Healthcare With A 7.51% Upside - DirectorsTalk Interviews
BrightSpring Health Services (BTSG) Goldman Sachs 47th Annual Global Healthcare Conference 2026 summary - Quartr
ETFs Investing in BrightSpring Health Services, Inc. Stocks - TradingView
Does BrightSpring’s S&P 400 Reclassification Alter the Bull Case for BrightSpring Health Services (BTSG)? - simplywall.st
Are medical stocks lagging BrightSpring Health Services, Inc. (BTSG) this year? - MSN
BrightSpring Health Services, Inc.(NasdaqGS: BTSG) added to S&P 400 - marketscreener.com
BrightSpring Health Services, Inc.(NasdaqGS:BTSG) dropped from S&P 600 Health Care Services (Sub Ind) - marketscreener.com
BrightSpring Health Services, Inc.(NasdaqGS: BTSG) dropped from S&P 600 Health Care - marketscreener.com
BrightSpring Health Services, Inc.(NasdaqGS: BTSG) dropped from S&P 600 - marketscreener.com
Goldman Sachs Maintains BrightSpring Health Services(BTSG.US) With Buy Rating, Raises Target Price to $80 - Moomoo
Why Is BrightSpring Health Services (NASDAQ:BTSG) Featured Among Midcap Stocks? - Kalkine Media
BrightSpring enters S&P MidCap 400 as Karman joins SmallCap 600 - Stock Titan
Analysts Conflicted on These Healthcare Names: BrightSpring Health Services, Inc. (BTSG) and Incyte (INCY) - The Globe and Mail
BrightSpring Health Services, Inc. Stock 12‑Month Price Target Raised to $76.76, Implies 10% Upside - TradingView
Morgan Stanley Maintains BrightSpring Health Services(BTSG.US) With Buy Rating, Raises Target Price to $80 - Moomoo
A Quick Look at Today's Ratings for BrightSpring Health Services(BTSG.US), With a Forecast Between $78 to $86 - Moomoo
Morgan Stanley Raises Price Target on BrightSpring Health Services to $80 From $71, Keeps Overweight Rating - Moomoo
BrightSpring Health Services, Inc. Stock 12‑Month Price Target Raised to $76.24, Implies 9% Upside - TradingView
Here's why you should add BrightSpring stock to your portfolio now - MSN
Guggenheim Initiates Coverage on BrightSpring Health Services With Buy Rating, $81 Price Target - marketscreener.com
Guggenheim Initiates BrightSpring Health Services(BTSG.US) With Buy Rating, Announces Target Price $81 - Moomoo
BrightSpring Health Services, I (BTSG): Investor Outlook Amid Strong Revenue Growth and Robust Analyst Ratings - DirectorsTalk Interviews
BrightSpring Health Services, Inc. (BTSG) is a great momentum stock: Should you buy? - MSN
Teladoc Health broadens virtual care reach through Walmart platform - MSN
Raymond James Maintains BrightSpring Health Services(BTSG.US) With Buy Rating, Maintains Target Price $80 - Moomoo
Jon Rousseau: Princeton Scholar, Healthcare Operator, and Chairman, President and Chief Executive Officer of BrightSpring Health Services - BBN Times
BrightSpring Health Services (BTSG) Q1 2026 Earnings Call Transcript - Fortune
This Travelers Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Benzinga
BTSG Initiated Coverage by Raymond James -- Rating Set to Outper - GuruFocus
Raymond James initiates BrightSpring Health stock with outperform rating - Investing.com
BrightSpring Health Services: Future Expectations May Be Fully Priced In - Seeking Alpha
BrightSpring Health Services to announce Q2 2026 results on July 31 - scanx.trade
BTSG Maintained by UBS -- Price Target Raised to $85.00 - GuruFocus
BrightSpring schedules Q2 results and 8:30 a.m. call for July 31 - Stock Titan
BrightSpring Health Services, Inc. to Announce Second Quarter 2026 Financial Results on July 31, 2026 - The Manila Times
Brightspring Health Services Inc Azioni (BTSG) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Brightspring Health Services Inc Azioni (BTSG) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| KKR Phoenix Aggregator L.P. | 10% Owner |
Jun 05 '26 |
Sale |
58.45 |
14,669,771 |
857,492,124 |
27,154,488 |
| ROUSSEAU JON B | See Remarks |
Jun 05 '26 |
Option Exercise |
6.37 |
130,000 |
828,100 |
130,000 |
| ROUSSEAU JON B | See Remarks |
Jun 05 '26 |
Option Exercise |
6.37 |
130,000 |
828,100 |
1,324,503 |
| ROUSSEAU JON B | See Remarks |
Jun 05 '26 |
Sale |
58.75 |
130,000 |
7,637,500 |
0 |
| ROUSSEAU JON B | See Remarks |
Jun 05 '26 |
Sale |
58.75 |
130,000 |
7,637,500 |
1,194,503 |
| Nalley Lisa A | See Remarks |
Jun 05 '26 |
Option Exercise |
6.37 |
35,000 |
222,950 |
166,948 |
| Nalley Lisa A | See Remarks |
Jun 05 '26 |
Sale |
58.75 |
35,000 |
2,056,250 |
131,948 |
| Phipps Jennifer A | Chief Financial Officer |
Jun 05 '26 |
Option Exercise |
6.37 |
35,000 |
222,950 |
285,224 |
| Phipps Jennifer A | Chief Financial Officer |
Jun 05 '26 |
Sale |
58.75 |
35,000 |
2,056,250 |
250,224 |
1.79%
2.93%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):